Fidelity Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$974M Sell
58,135,616
-24,606,400
-30% -$412M 0.05% 283
2025
Q1
$1.27B Buy
82,742,016
+758,785
+0.9% +$11.7M 0.08% 204
2024
Q4
$1.81B Buy
81,983,231
+19,242,468
+31% +$424M 0.11% 142
2024
Q3
$1.13B Buy
62,740,763
+20,762,226
+49% +$374M 0.07% 240
2024
Q2
$682M Buy
41,978,537
+20,730,130
+98% +$337M 0.04% 343
2024
Q1
$300M Buy
21,248,407
+18,523,048
+680% +$261M 0.02% 626
2023
Q4
$28.5M Buy
2,725,359
+161,020
+6% +$1.68M ﹤0.01% 1493
2023
Q3
$26.2M Buy
2,564,339
+2,494,156
+3,554% +$25.4M ﹤0.01% 1481
2023
Q2
$528K Sell
70,183
-74,473
-51% -$561K ﹤0.01% 2640
2023
Q1
$1.28M Buy
144,656
+972
+0.7% +$8.6K ﹤0.01% 2470
2022
Q4
$1.31M Buy
143,684
+53,978
+60% +$492K ﹤0.01% 2480
2022
Q3
$724K Sell
89,706
-18,617
-17% -$150K ﹤0.01% 2680
2022
Q2
$815K Buy
108,323
+49,182
+83% +$370K ﹤0.01% 2727
2022
Q1
$555K Sell
59,141
-62,921
-52% -$590K ﹤0.01% 2952
2021
Q4
$978K Buy
122,062
+69,427
+132% +$556K ﹤0.01% 2691
2021
Q3
$513K Buy
52,635
+7,150
+16% +$69.7K ﹤0.01% 2789
2021
Q2
$450K Sell
45,485
-3,543
-7% -$35.1K ﹤0.01% 2785
2021
Q1
$566K Buy
49,028
+5,005
+11% +$57.8K ﹤0.01% 2666
2020
Q4
$425K Buy
44,023
+13,267
+43% +$128K ﹤0.01% 2674
2020
Q3
$277K Sell
30,756
-8,141,989
-100% -$73.3M ﹤0.01% 2651
2020
Q2
$101M Buy
8,172,745
+7,019,822
+609% +$86.6M 0.01% 868
2020
Q1
$10.4M Buy
1,152,923
+459,239
+66% +$4.12M ﹤0.01% 1680
2019
Q4
$6.8M Sell
693,684
-209,727
-23% -$2.06M ﹤0.01% 1973
2019
Q3
$6.22M Sell
903,411
-5,192,953
-85% -$35.7M ﹤0.01% 1983
2019
Q2
$56.3M Sell
6,096,364
-10,968,226
-64% -$101M 0.01% 1163
2019
Q1
$268M Sell
17,064,590
-18,184,075
-52% -$285M 0.03% 542
2018
Q4
$544M Buy
35,248,665
+10,766,729
+44% +$166M 0.07% 260
2018
Q3
$527M Buy
24,481,936
+3,921,785
+19% +$84.5M 0.06% 315
2018
Q2
$500M Sell
20,560,151
-1,953,820
-9% -$47.5M 0.06% 320
2018
Q1
$385M Sell
22,513,971
-2,146,183
-9% -$36.7M 0.05% 416
2017
Q4
$467M Sell
24,660,154
-1,444,706
-6% -$27.4M 0.05% 371
2017
Q3
$459M Sell
26,104,860
-16,740,119
-39% -$295M 0.06% 358
2017
Q2
$1.42B Buy
42,844,979
+6,115,853
+17% +$203M 0.18% 110
2017
Q1
$1.18B Sell
36,729,126
-26,276,489
-42% -$843M 0.15% 136
2016
Q4
$2.28B Sell
63,005,615
-4,550,472
-7% -$165M 0.31% 63
2016
Q3
$3.11B Sell
67,556,087
-794,371
-1% -$36.5M 0.41% 41
2016
Q2
$3.43B Sell
68,350,458
-9,586,398
-12% -$482M 0.47% 39
2016
Q1
$4.17B Sell
77,936,856
-7,391,035
-9% -$395M 0.58% 26
2015
Q4
$5.6B Buy
85,327,891
+12,481,459
+17% +$819M 0.75% 17
2015
Q3
$4.11B Buy
72,846,432
+7,852,764
+12% +$443M 0.59% 25
2015
Q2
$3.84B Buy
64,993,668
+8,918,008
+16% +$527M 0.49% 29
2015
Q1
$3.49B Buy
56,075,660
+9,032,830
+19% +$563M 0.45% 34
2014
Q4
$2.71B Buy
47,042,830
+7,104,441
+18% +$409M 0.35% 48
2014
Q3
$2.15B Buy
39,938,389
+191,292
+0.5% +$10.3M 0.29% 67
2014
Q2
$2.08B Buy
39,747,097
+12,733,185
+47% +$667M 0.28% 68
2014
Q1
$1.43B Buy
27,013,912
+17,601,258
+187% +$930M 0.2% 100
2013
Q4
$377M Buy
9,412,654
+742,053
+9% +$29.7M 0.05% 381
2013
Q3
$328M Buy
8,670,601
+5,385,512
+164% +$203M 0.05% 421
2013
Q2
$129M Buy
+3,285,089
New +$129M 0.02% 796